期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 11, 期 4, 页码 329-336出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2006.09.005
关键词
macrolides; antimicrobial drug; resistance; Streptococcus pneumoniae; Staphylococcus enterococcus
Objective: The characterization of macrolide resistance in Gram-positive cocci recovered from Colombian hospitals. Methods: The resistance profiles and mechanism of macrolide resistance were investigated in isolates of Streptococcus pneumoniae (1679), Staphylococcus aureus (348), coagulase- negative staphylococci (CoNS) (175), and Enterococcus spp (123). Minimum inhibitory concentrations (MICs) for erythromycin (ERY) and clindamycin (CLI), detection of macrolide resistance genes, phenotypic characterization, and pulsed field get electrophoresis (PFGE) of macrolide- resistant pneumococci were performed. Results: Resistance to ERY and CLI was 3.3% and 2.3% for S. pneumoniae, 58% and 57% for S. aureus (94% for both compounds in methicillin- resistant Staphylococcus aureus (MRSA)), and 78.6% and 60.7% in methicillin-resistant Staphylococcus epidermidis, respectively. ERY resistance was 62% in Enterococcus faecalis and 82% in Enterococcus faecium. The MLSB-type accounted for 71% of S. pneumoniae and 100% of MRSA. The erm(A) gene was prevalent in MRSA, erm(B) in S. pneumoniae and enterococci, and erm(C) in CoNS isolates. Efflux pump genes (mef(A) genes) were mostly identified in S. pneumoniae (24%). The most common genotype amongst ERY-resistant pneumococci was the Spain(6B)-2 clone. Conclusions: The prevalence of macrolide resistance is low in Colombian pneumococci and high in MRSA (cMLS(B)-type). (C) 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据